183 related articles for article (PubMed ID: 9727041)
1. High constitutive activity of the human formyl peptide receptor.
Wenzel-Seifert K; Hurt CM; Seifert R
J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
[TBL] [Abstract][Full Text] [Related]
3. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state.
Seifert R; Wenzel-Seifert K
Recept Channels; 2001; 7(5):357-69. PubMed ID: 11697079
[TBL] [Abstract][Full Text] [Related]
4. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis.
Seifert R; Wenzel-Seifert K
J Biol Chem; 2001 Nov; 276(45):42043-9. PubMed ID: 11559706
[TBL] [Abstract][Full Text] [Related]
5. Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.
Wenzel-Seifert K; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):509-15. PubMed ID: 12679864
[TBL] [Abstract][Full Text] [Related]
6. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors.
Seifert R; Wenzel-Seifert K
Life Sci; 2003 Sep; 73(18):2263-80. PubMed ID: 12941430
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
Wenzel-Seifert K; Seifert R
J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
[TBL] [Abstract][Full Text] [Related]
8. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
[TBL] [Abstract][Full Text] [Related]
9. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
[TBL] [Abstract][Full Text] [Related]
10. Contribution of nucleoside diphosphokinase to guanine nucleotide regulation of agonist binding to formyl peptide receptors.
Wieland T; Bremerich J; Gierschik P; Jakobs KH
Eur J Pharmacol; 1991 Sep; 208(1):17-23. PubMed ID: 1657618
[TBL] [Abstract][Full Text] [Related]
11. Relationship of ligand-receptor dynamics to actin polymerization in RBL-2H3 cells transfected with the human formyl peptide receptor.
Hall AL; Wilson BS; Pfeiffer JR; Oliver JM; Sklar LA
J Leukoc Biol; 1997 Oct; 62(4):535-46. PubMed ID: 9335325
[TBL] [Abstract][Full Text] [Related]
12. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor.
Wenzel-Seifert K; Seifert R
Biochem Biophys Res Commun; 2003 Feb; 301(3):693-8. PubMed ID: 12565836
[TBL] [Abstract][Full Text] [Related]
13. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
[TBL] [Abstract][Full Text] [Related]
14. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
Bennett TA; Maestas DC; Prossnitz ER
J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
[TBL] [Abstract][Full Text] [Related]
15. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
[TBL] [Abstract][Full Text] [Related]
16. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
Graham TE; Prossnitz ER; Dorin RI
J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
[TBL] [Abstract][Full Text] [Related]
17. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
18. Role of isoprenoid metabolism in chemotactic peptide receptor-mediated G protein activation.
McLeish KR; Lederer ED; Klein JB
Biochem Biophys Res Commun; 1993 Dec; 197(2):763-70. PubMed ID: 8267613
[TBL] [Abstract][Full Text] [Related]
19. The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications.
Ye RD; Quehenberger O; Thomas KM; Navarro J; Cavanagh SL; Prossnitz ER; Cochrane CG
J Immunol; 1993 Feb; 150(4):1383-94. PubMed ID: 8432984
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma enhances expression of formyl peptide receptors and guanine nucleotide-binding proteins by HL-60 granulocytes.
Klein JB; Scherzer JA; McLeish KR
J Immunol; 1992 Apr; 148(8):2483-8. PubMed ID: 1560204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
